82 results
10-Q
2014 Q2
RGBP
Regen BioPharma Inc
5 May 14
Quarterly report
12:00am
Inception to
(April 24, 2012) to
(unaudited)
REVENUES
COST AND EXPENSES
Research and Development
General and Administrative
Consulting and Professional … and administrative , research and development, and consulting expenses incurred during the quarter ended March 31, 2014 when compared to the quarter ended March 31
8-K
EX-10.1
RGBP
Regen BioPharma Inc
8 Apr 21
Entry into a Material Definitive Agreement
10:08am
, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub … -licensing or sub-contracting of these activities.
“Develop” or “Development” shall mean pre-clinical and clinical research and development activities
424B3
jnmy4 i9a
19 Mar 14
Prospectus supplement
12:00am
8-K
EX-10.1
wz6ejuh5cn
25 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
7hgca8 ik
8 Apr 21
Entry into a Material Definitive Agreement
10:08am
10-K
8wqcwpm
18 Dec 14
Annual report
12:00am